Famotidine for Horses: Uses, Dosing & Side Effects

This information is for educational purposes only. Never give your pet any medication without your veterinarian's guidance. Dosing, frequency, and safety depend on your pet's specific health profile.

Famotidine is an H2-receptor blocker that lowers stomach acid production. In horses, your vet may use it as an extra-label medication to help manage acid-related stomach irritation, especially when gastric ulcers, reflux, or esophageal irritation are concerns. It is not the main FDA-approved ulcer treatment for horses, but it is still used in selected cases when your vet wants another acid-suppressing option.

Famotidine works by blocking histamine signals at the stomach's acid-producing cells. That can raise stomach pH for a period of time and may help reduce ongoing acid injury. In horses, though, H2 blockers usually need more frequent dosing than proton pump inhibitors, and many equine specialists consider them less reliable than omeprazole for healing equine gastric ulcer disease.

Because horses vary in size, feeding schedule, ulcer type, and other medications, famotidine should be used only under your vet's direction. Your vet may also pair medication with management changes like more forage access, lower-starch feeding plans, reduced fasting time, and stress reduction.

In horses, famotidine is most often used for gastric acid suppression. Your vet may consider it for horses with suspected or confirmed equine gastric ulcer syndrome (EGUS), including cases where acid reduction is part of a broader treatment plan. It may also be used when a horse has signs that fit upper digestive irritation, such as poor appetite, attitude changes around girthing, recurrent mild colic, or discomfort linked to meals.

Some vets use famotidine as supportive care for horses with esophagitis, gastritis, or acid-related irritation during hospitalization, transport stress, illness, or periods of reduced feed intake. In foals and critically ill patients, acid suppression may be considered case by case, but the decision depends heavily on the horse's age, diagnosis, and overall stability.

Famotidine is usually not the first-choice medication when the goal is complete treatment of equine gastric ulcers. Current equine references note that omeprazole is the only FDA-approved medication for treatment and prevention of recurrence of EGUS in horses, and H2 blockers like famotidine are generally considered alternative or adjunct options rather than the default first-line plan.

Do not dose famotidine without your vet's instructions. Published equine references list famotidine at about 0.4 mg/kg IV every 12 hours or 3 mg/kg by mouth every 12 hours in adult horses. Some neonatal and foal references list ranges around 0.25-0.5 mg/kg IV three times daily or 2-4 mg/kg by mouth three times daily, but foal dosing should always come directly from your vet because age and illness severity matter.

In real-world practice, the exact plan depends on why your vet is using it, whether the horse is eating normally, and whether the medication is being given as tablets, compounded paste, or injectable product. Oral dosing can be challenging in horses because the total milligram amount is large, and compounded formulations may be needed for practical administration.

Your vet may recommend giving famotidine on a schedule that fits feeding and other medications. If sucralfate, antacids, or multiple ulcer medications are also being used, timing can matter. Do not change the dose, stop early, or combine acid reducers on your own, because that can make treatment less effective or complicate follow-up if your horse is not improving.

Famotidine is generally considered well tolerated, but side effects are still possible. In horses, the most common concerns are usually practical rather than dramatic: poor acceptance of oral medication, missed doses, or limited response if the underlying problem is not truly acid-related. If your horse seems worse instead of better, contact your vet rather than assuming the medication will fix it with more time.

Potential adverse effects reported for famotidine across veterinary use include decreased appetite, diarrhea, and rarely changes in blood cell counts. Injectable use can also carry the usual risks of IV medication administration. Horses with significant kidney, liver, or heart disease may need closer oversight because drug handling and overall safety can change.

Call your vet promptly if you notice worsening colic signs, marked depression, persistent diarrhea, refusal to eat, trouble swallowing, or any new signs after starting the medication. Those problems may reflect the underlying disease, a medication issue, or a different diagnosis that needs a new plan.

Famotidine can interact with the timing or absorption of other medications. Acid suppression changes stomach pH, which may affect how some oral drugs dissolve or are absorbed. If your horse is taking several medications, your vet may want a specific schedule rather than giving everything together.

Equine references note that famotidine may be administered with antacids, while other protectants such as sucralfate often need careful spacing from other oral medications. In practice, your vet may separate these drugs by time to reduce the chance that one product interferes with another.

Be sure your vet knows about NSAIDs like phenylbutazone or flunixin meglumine, ulcer medications such as omeprazole or sucralfate, supplements, and any compounded products. NSAIDs do not create a direct famotidine interaction in the usual sense, but they can contribute to gastrointestinal injury, which changes the overall treatment plan and monitoring needs.